Literature DB >> 10725793

Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines.

T A Hamilton1, Y Ohmori, J M Tebo, R Kishore.   

Abstract

The anti-inflammatory cytokines IL-4 and IL-10 are well recognized as important negative regulators of proinflammatory gene expression in mononuclear phagocytes. The intracellular mechanisms which mediate these responses appear to be multifactorial. IL-4 is able to markedly suppress transcriptional activation of IFNgamma-responsive genes and the promoter sequences required for both IFNgamma and IL-4 sensitivity are identical. IFNgamma-activated STAT1 and IL-4-activated STAT6 can both form complexes on the same regulatory sequence element; while STAT1 functions to promote transcription, STAT6 is inactive. STAT6 is, however, required for the suppressive activity of IL-4. In this model, IL-4 appears to suppress IFNgamma-inducible proinflammatory gene expression through the ability of STAT6 to compete with STAT1 for occupancy of promoter sites necessary for IFNgamma-induced transcriptional initiation. In a second model, IL-10 suppresses the expression of genes induced in LPS-stimulated macrophages through a pathway involving destabilization of specific mRNAs. We have demonstrated that nucleotide sequences in the 3'-untranslated region of an IL-10-sensitive gene can both destabilize a stable reporter mRNA (CAT) and confer sensitivity to IL-10-mediated destabilization. Deletion and site-specific mutagenesis have mapped this to an AU-rich sequence motif similar to that found in many cytokine and growth factor mRNAs. IL-10 is able to modulate the activity of proteins capable of binding to this sequence and one or more of these may regulate the rate of mRNA degradation. Thus mechanisms through which IL-10 and IL-4 act to dampen inflammatory responses are mechanistically distinct and involve diverse intracellular signaling pathways. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10725793     DOI: 10.1159/000028101

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  24 in total

Review 1.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

Review 2.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

Review 3.  An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.

Authors:  Gaosi Xu; Wenjun Yan; Jingzhen Li
Journal:  Clin Exp Nephrol       Date:  2014-04-22       Impact factor: 2.801

Review 4.  Fine-tuning the central nervous system: microglial modelling of cells and synapses.

Authors:  Anna L Xavier; João R L Menezes; Steven A Goldman; Maiken Nedergaard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-19       Impact factor: 6.237

5.  Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages.

Authors:  Smita Misra; Manish K Tripathi; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2005-06-14       Impact factor: 5.157

6.  Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism.

Authors:  Zoltán H Németh; Carol S Lutz; Balázs Csóka; Edwin A Deitch; S Joseph Leibovich; William C Gause; Masahide Tone; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

7.  Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection.

Authors:  Sanbao Ruan; Chandra Tate; Janet J Lee; Thomas Ritter; Jay K Kolls; Judd E Shellito
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 8.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

9.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.